We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

754 hedge funds and large institutions have $55.9B invested in Allergan plc in 2014 Q3 according to their latest regulatory filings, with 139 funds opening new positions, 374 increasing their positions, 189 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

184% more first-time investments, than exits

New positions opened: 139 | Existing positions closed: 49

98% more repeat investments, than reductions

Existing positions increased: 374 | Existing positions reduced: 189

91% more call options, than puts

Call options by funds: $2.01B | Put options by funds: $1.05B

42% more capital invested

Capital invested by funds: $39.4B → $55.9B (+$16.5B)

35% more funds holding in top 10

Funds holding in top 10: 84113 (+29)

12% more funds holding

Funds holding: 674754 (+80)

Holders
754
Holders Change
+80
Holders Change %
+11.87%
% of All Funds
21.82%
Holding in Top 10
113
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+34.52%
% of All Funds
3.27%
New
139
Increased
374
Reduced
189
Closed
49
Calls
$2.01B
Puts
$1.05B
Net Calls
+$954M
Net Calls Change
+$468M

AGN Hedge Fund Activity: Q3 2014 in Review

754 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2014, worth a combined $55.9B — up 42% from $39.4B a quarter earlier.

Buyers outnumbered sellers: 139 funds opened new AGN positions and 49 closed out — a net gain of 90 holders — while 374 added to existing stakes and 189 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $1.74B. The largest seller was AllianceBernstein, cutting an estimated $200M.

  • 754 institutional investors held Allergan plc (AGN) as of Q3 2014, up from 674 in Q2 2014.
  • Funds reported $55.9B of Allergan plc stock for Q3 2014, up 42% quarter-over-quarter.
  • 139 funds opened new Allergan plc positions in Q3 2014 and 49 closed out, a net change of +90 holders.
  • The largest Allergan plc buyer in Q3 2014 was ClearBridge Investments, an estimated $1.74B added.
  • The largest Allergan plc seller in Q3 2014 was AllianceBernstein, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2014.